ORKA
Oruka Therapeutics, Inc. Common Stock
ORKA
ORKA
66 hedge funds and large institutions have $607M invested in Oruka Therapeutics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 20 increasing their positions, 8 reducing their positions, and 4 closing their positions.
Holders
66
Holders Change
+25
Holders Change %
+60.98%
% of All Funds
0.88%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
29
Increased
20
Reduced
8
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$31.2M |
2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$25.7M |
3 |
![]()
3
Fidelity Investments
Boston,
Massachusetts
|
$107M |
4 |
B
4
Braidwell
Stamford,
Connecticut
|
$27.1M |
5 |
5
BlackRock
New York
|
$14.6M |